TrialJournal of hematology & oncology2013

Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models.

Michela Capello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.